Cerebral Vasospasm Registry Using NeVa VS After Aneurysmal Subarachnoid Hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-center observational registry collects data on patients treated with the NeVa VS cerebral artery dilation device for symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. It includes adults 22 and older and follows patients through the post-procedure period to document outcomes and device performance. Data are gathered from participating centers to understand safety, feasibility, and patterns of use in routine clinical practice. The study design is non-randomized and relies on standard-of-care treatment decisions made by treating physicians. No control group is planned, and findings will be descriptive and hypothesis-generating for future research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥22
2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
3. Vessel dilation procedure was performed with the NeVa VS
4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure

Exclusion Criteria:

* None

Where it's running

• Providence St. Joseph Medical Center
  Burbank, California, United States Recruiting
• John Muir Health
  Walnut Creek, California, United States Recruiting
• Yale
  New Haven, Connecticut, United States Recruiting
• Baptist Health South Florida
  Miami, Florida, United States Recruiting
• Wellstar Health System
  Marietta, Georgia, United States Recruiting
• Endeavor Health
  Evanston, Illinois, United States Recruiting

Study contacts

• Study coordinator: Sharon Shachar, Graduate
• Email: sshachar@vesalio.com
• Phone: 2486976616

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nitric Oxide Use to Predict Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  This study tests whether nitric oxide consumption in CSF can predict cerebral vasospasm in patients with aneurysmal SAH.

  Recruiting at 2 sites Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT07614906

• Scalp block for headache after aneurysmal subarachnoid hemorrhage in ICU patients

  We are testing whether a levobupivacaine scalp block added to standard pain medicines can reduce severe headache in adults in the ICU after aneurysmal subarachnoid hemorrhage treated endovascularly.

  Recruiting Hamad Medical Corporation · Doha · NCT07307508

• Tracking delayed ischemic neurological deficits in people with aneurysmal subarachnoid hemorrhage — real-world data

  This project will collect real-world monitoring and treatment information to see how often delayed ischemic neurological deficits (DIND) happen and what diagnostic and treatment approaches people with aneurysmal subarachnoid hemorrhage receive.

  Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07160088

• Intranasal sphenopalatine ganglion block for headache after a ruptured brain aneurysm

  This will test whether spraying a numbing medicine into the back of the nose can reduce severe headache in adults recovering from a ruptured brain aneurysm.

  Recruiting Phase 4 Wright State University · Dayton, Ohio · NCT07116408

• Understanding cerebral vasospasm in traumatic brain injury with subarachnoid hemorrhage

  This study is testing how common and serious blood vessel narrowing in the brain is for adults with moderate to severe traumatic brain injuries and bleeding, to see if better scans can help improve their care.

  Recruiting University Hospital Center of Martinique · Fort-de-France · NCT06560372

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.